Based on the reported P/B of 1.03 and a price of $118.48 against tangible book value of $109.97 per share in 2026Q3, Citigroup trades at roughly 1.08 times tangible book, a level that prices the franchise close to its net asset base rather than as a premium earner. Investors should monitor whether ROTCE recovers enough to justify that multiple. Forward P/E of 10.41 versus trailing 16.95 implies the market expects earnings to rebound from the depressed 2025Q4 base, though that expectation rests on volatile quarterly results. Comparing against peers, Citigroup's P/B of 1.03 sits below JPM at 2.60 and MS at 2.58 but in line with BAC at 1.24, suggesting the market still discounts its returns relative to the higher-quality franchises.

According to the reported ratios, ROE moved from 1.6% in 2024Q1 to 2.5% in 2026Q3, but the path was uneven, dipping to 1.1% in 2025Q4 and recovering to 2.7% in 2026Q1, with fee share swinging between 21.2% and 35.4%. The ROE remains well below the 10% to 17% range of peers. Decomposing through the DuPont framework, the net interest margin has been steady near 0.5% to 0.6%, so the improvement appears tied to non-interest income and efficiency gains rather than balance sheet leverage. Leverage is actually compressed, with equity to total assets near 0.07 to 0.09, which limits ROE upside from gearing.

Based on reported figures, the efficiency ratio improved from 67.3% in 2024Q1 to 58.5% in 2026Q3, indicating expense discipline has outpaced revenue growth, while NIM held in a narrow 0.5% to 0.6% band across the ten quarters. The efficiency gain is the main driver of profitability improvement rather than margin expansion. Reported figures suggest operating leverage is working in management's favor, though the 58.5% level still trails the stronger franchises and leaves less room for error if revenues soften. The stable NIM suggests funding costs and asset yields have roughly offset each other during the period.

Based on Citigroup's reported equity-to-assets ratio of roughly 0.07 in 2026Q3, down from about 0.09 in 2024Q1, the capital cushion has narrowed as total assets expanded roughly 21% while equity grew only modestly. Capital adequacy ratios such as CET1 are not included in the supplied data, so regulatory headroom cannot be assessed directly. The thinning equity base suggests limited capacity for large capital returns without first rebuilding retained earnings, and the dividend yield of 2.4% carries a relatively heavy claim on earnings given the 2.5% ROE.

As reported in the financial statements, quarterly provisions held between $2.2B and $2.9B across the period, including $2.6B in both 2026Q3 and 2026Q1, a level that absorbs a meaningful share of quarterly net interest income of $15.7B to $17.0B. Non-performing loan and charge-off ratios are not included in the supplied data, so reserve adequacy cannot be directly tested. The persistence of elevated provisions suggests credit costs remain a structural drag on earnings rather than a one-time item.